| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.03 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.035 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.029 | 0.9 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.9 |